Patient Case Study - Individualising Antithrombotic Strategies for Established CAD

Published: 02 January 2023

  • Views:

    Views Icon 1307
  • Likes:

    Heart Icon 7
Average (ratings)
No ratings
Your rating

Overview

This patient case study is part of the programme 'Individualising Antithrombotic Strategies for Established CAD'.

 

In this short video, Prof Pascal Vranckx (Hartcentrum Hasselt, BE) presents a complex 62-year old male with stable angina and HFrEF, undergoing an elective angiography. Watch this case presentation and vote on what the optimal anti-platelet strategy is for this patient.

 

This case, and its management strategy, will be discussed in a live roundtable discussion on 22 February 2023. The panel will also offer practical solutions to challenges experienced in daily practice. Register now to attend! 

 

 

 

This programme is supported by an unrestricted educational grant from AstraZeneca.

Learning Objectives

  • Stratify patients according to bleeding and ischaemic risk
  • Select antithrombotic regimens according bleeding and ischaemic risk

Target Audience

  • General Cardiologists
  • Interventional Cardiologists
  • Nurses
  • HCPs

More from this programme

Part 1

Case Study: Patient with CCS

Prof Pascal Vranckx presents a complex 62-year old male with stable angina and HFrEF, undergoing an elective angiography.

Faculty Biographies

Pascal Vranckx

Pascal Vranckx

Clinical Consultant in Interventional Cardiology and Medical Director of Cardiac Critical Care Services

Prof Pascal Vranckx is a Clinical Consultant in Interventional Cardiology and Medical Director of Cardiac Critical Care Services at the Hartcentrum Hasselt in Belgium, and Professor of Medicine at the University of Hasselt, Belgium.

Prof Vranckx is also board member of the European Cardiovascular Research Institute, in Rotterdam, The Netherlands. 

View full profile